CD4(+) T Cell and NK Cell Interplay Key to Regression of MHC Class I-low Tumors upon TLR7/8 Agonist Therapy
Author(s):
Doorduijn, E.M.; Sluijter, M.; Salvatori, D.C.; Silvestri, S.; Maas, S.; Arens, R.; Ossendorp, F.; Burg, S.H. van der (0000-0002-6556-0354); Hall, T. van (0000-0002-9115-558X)
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-08-31
Language
English
Is part of
Cancer Immunology Research (2017), Vol. 5, no. 8, p. 642-653
